Laura Jean Bierut

Laura Jean Bierut

Auto-generated profile, based on publicly available information

Laura Jean Bierut

Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 April 2024 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
CNCaroline Nievergelt
Caroline Nievergelt
AMAdam X. Maihofer
Adam X. Maihofer
EAElizabeth G. Atkinson
Elizabeth G. Atkinson
CCChia-Yen Chen
Chia-Yen Chen
KCKarmel W. Choi
Karmel W. Choi
KKKarestan C. Koenen
Karestan C. Koenen

4 October 2011 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
LBL J Bierut
L J Bierut
AGAlison Goate
Alison Goate
NBN Breslau
N Breslau
EJE O Johnson
E O Johnson
SBS Bertelsen
S Bertelsen
HEH J Edenberg
H J Edenberg
A coding variant in alcohol dehydrogenase 1B (ADH1B) (rs1229984) that leads to the replacement of Arg48 with His48 is common in Asian populations and reduces their risk for alcoholism, but because of very low allele frequencies the effects in European or African populations have been difficult to detect. We genotyped and analyzed this variant in three large European and African-American case–control studies in which alcohol dependence was defined by the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria, and demonstrated a strong protective effect of the His48 variant (odds ratio (OR) 0.34, 95% confidence interval (CI) 0.24, 0.48) on alcohol dependence, with genome-wide significance (6.6 × 10–10). The hypothesized mechanism of action involves an increased aversive reaction to alcohol; in keeping with this hypothesis, the same allele is strongly associated with a lower maximum number of drinks in a 24-hour period (lifetime), with P=3 × 10–13. We also tested the effects of this allele on the development of alcoholism in adolescents and young adults, and demonstrated a significantly protective effect. This variant has the strongest effect on risk for alcohol dependence compared with any other tested variant in European populations.

1 February 2011 in Neuron
Verified
Journal Article
Closed access
LBLaura Jean Bierut
Laura Jean Bierut

1 November 2017 in Drug and Alcohol Dependence
Verified
Journal Article
Closed access
AEAnastasia B. Evanoff
Anastasia B. Evanoff
TQTiffany Quan
Tiffany Quan
CDCarolyn Dufault
Carolyn Dufault
MAMichael Awad
Michael Awad
LBLaura Jean Bierut
Laura Jean Bierut

3 November 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
BQBryan C. Quach
Bryan C. Quach
MBMichael J. Bray
Michael J. Bray
NGNathan C. Gaddis
Nathan C. Gaddis
MLMengzhen Liu
Mengzhen Liu
TPTeemu Palviainen
Teemu Palviainen
DHDana B. Hancock
Dana B. Hancock
Cigarette smoking is the leading cause of preventable morbidity and mortality. Genetic variation contributes to initiation, regular smoking, nicotine dependence, and cessation. We present a Fagerström Test for Nicotine Dependence (FTND)-based genome-wide association study in 58,000 European or African ancestry smokers. We observe five genome-wide significant loci, including previously unreported loci MAGI2/GNAI1 (rs2714700) and TENM2 (rs1862416), and extend loci reported for other smoking traits to nicotine dependence. Using the heaviness of smoking index from UK Biobank (N = 33,791), rs2714700 is consistently associated; rs1862416 is not associated, likely reflecting nicotine dependence features not captured by the heaviness of smoking index. Both variants influence nearby gene expression (rs2714700/MAGI2-AS3 in hippocampus; rs1862416/TENM2 in lung), and expression of genes spanning nicotine dependence-associated variants is enriched in cerebellum. Nicotine dependence (SNP-based heritability = 8.6%) is genetically correlated with 18 other smoking traits (rg = 0.40–1.09) and co-morbidities. Our results highlight nicotine dependence-specific loci, emphasizing the FTND as a composite phenotype that expands genetic knowledge of smoking.

1 May 2017 in Drug and Alcohol Dependence
Verified
Journal Article
Closed access
MKMelissa J. Krauss
Melissa J. Krauss
SSShaina J. Sowles
Shaina J. Sowles
ASAuriann Sehi
Auriann Sehi
ESEdward L. Spitznagel
Edward L. Spitznagel
CBCarla Berg
Carla Berg
PCPatricia Cavazos-Rehg
Patricia Cavazos-Rehg